Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-01-10 @ 3:12 PM
Study NCT ID:
NCT00989651
Status:
COMPLETED
Last Update Posted:
2021-10-20
First Post:
2009-10-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-02
First Submit QC Date:
None
Study First Post Date:
2009-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-19
Last Update Post Date:
2021-10-20
Last Update Post Date Type:
ACTUAL